Shanghai - Delayed Quote
CNY
Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
41.05
-0.72
(-1.72%)
At close: October 30 at 3:00:01 PM GMT+8
Loading chart for 688513.SS
- Previous Close
41.77 - Open
41.12 - Bid 41.03 x --
- Ask 41.05 x --
- Day's Range
40.88 - 43.09 - 52 Week Range
40.25 - 80.48 - Volume
1,096,497 - Avg. Volume
2,241,756 - Market Cap (intraday)
7.247B - Beta (5Y Monthly) --
- PE Ratio (TTM)
25.98 - EPS (TTM)
1.58 - Earnings Date --
- Forward Dividend & Yield 0.49 (1.19%)
- Ex-Dividend Date Jun 2, 2026
- 1y Target Est
62.00
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
688513.SS
32.63%
SSE Composite Index (000001.SS)
9.32%
1-Year Return
688513.SS
22.26%
SSE Composite Index (000001.SS)
9.73%
3-Year Return
688513.SS
13.64%
SSE Composite Index (000001.SS)
19.11%
5-Year Return
688513.SS
44.94%
SSE Composite Index (000001.SS)
1.46%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
20.92%
-
Return on Assets (ttm)
2.84%
-
Return on Equity (ttm)
7.77%
-
Revenue (ttm)
1.3B
-
Net Income Avi to Common (ttm)
272.52M
-
Diluted EPS (ttm)
1.58
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.76B
-
Total Debt/Equity (mrq)
6.69%
-
Levered Free Cash Flow (ttm)
202.14M
